First-in-Human Stage III/IV Melanoma Clinical Trial of Immune Priming Agent IFx-Hu2.0
免疫启动剂 IFx-Hu2.0 的首次人体 III/IV 期黑色素瘤临床试验
期刊:Molecular Cancer Therapeutics
影响因子:5.5
doi:10.1158/1535-7163.MCT-23-0652
Markowitz, Joseph; Shamblott, Michael; Brohl, Andrew S; Sarnaik, Amod A; Eroglu, Zeynep; Khushalani, Nikhil I; Dukes, Christopher W; Chamizo, Alejandra; Bastawrous, Marina; Garcia, Edward T; Dehlawi, Ashraf; Chen, Pei-Ling; De Aquino, Deanryan B; Sondak, Vernon K; Tarhini, Ahmad A; Kim, Youngchul; Lawman, Patricia; Pilon-Thomas, Shari